• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

NBS:US

3.3400 USD 0.0900 2.77%

As of 20:10:00 ET on 12/19/2014.

Snapshot for NeoStem Inc (NBS)

Open: 3.2400 Day's Range: 3.1800 - 3.3800 Volume: 322,557
Previous Close: 3.2500 52wk Range: 3.0800 - 8.2900 1-Yr Rtn: -46.47%

Stock Chart for NBS

No chart data available.
  • NBS:US 3.3400
  • 1D
  • 1M
  • 1Y
3.2500
Interactive NBS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NBS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8400
Est. EPS (USD) (12/2014) -1.7750
Est. PEG Ratio -
Market Cap (M USD) 119.37
Shares Outstanding (M) 35.74
30 Day Average Volume 713,812
Price/Book (mrq) 1.8812
Price/Sale (ttm) 6.0010
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NBS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NBS

NeoStem, Inc. develops and manufactures cell therapies. The Company through its subsidiaries offers contract manufacturing services and is developing a cell therapy for the treatment of cardiovascular disease.

Robin L SmithChief Executive OfficerRobert Dickey IVChief Financial Officer
Andrew L PecoraChief Visionary OfficerDouglas W LosordoChief Medical Officer
More Company Profile & Key Executives for NBS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • NBS News

  • Industry News

Advertisement
Sponsored Links
Advertisements
sec ||= nil